TABLE 6.

Comparison of virulence profiles of nasal carriage MSSA and clinical MSSA USA400 pulsed-field pulsotypes with three representative strains of USA400 CA-MRSAa

Isolate group and yrSamplesehssl1lpl10sdrCsdrDsdrEearsecsec4selsel2clfahlabsalukSF-PVlukDlukEseaseg2sekhlbhldhlgBfnbBfnbAclfBicaAcnasebsedseesegseisejsemsenseoetaetbtst
Nasal MSSA
    2003UWL-57-S+++++++++++++++++++++
    2004UWL-83-S+++++++++++++++++++++++
    2003UWL-33-S++++++++++++++++++++++++++
    2005UWL-92-S+++++++++++++++++++++
    2001MNDH-125-S+++++++++++++++++++++++++++++++++++
    2000MNDH-97-S++++++++++++++++++++++++
Clinical MSSA
    1998MNDH-77-S+++++++++++++++++++++++++++++++++
    1987WSLH-6-S+++++++++++++++++++++++++++
    2004MC-112-S++++++++++++++++++++++++++
    2002WSLH-32-S++++++++++++++++++++++++++
    2003WSLH-35-S+++++++++++++++++++++
    2004MC-127-S++++++++++++++++++++++++
    1997MNDH-31-S++++++++++++++++++++++++++++++++++
    2004MC-118-S++++++++++++++++++++++++++++
CA-MRSA
    199234-R+++++++++++++++++++++++++++
    199388-R++++++++++++++++++++++
    1994169-R++++++++++++++++++++++++
  • a −, PCR negative; +, PCR positive.